Literature DB >> 23375208

Chronic rhinosinusitis with polyps and without polyps is associated with increased expression of suppressors of cytokine signaling 1 and 3.

Se Jin Park1, Tae Hoon Kim, Young Joon Jun, Seung Hoon Lee, Hyei Yul Ryu, Kwang Jin Jung, Jong Yoon Jung, Gyu Ho Hwang, Sang Hag Lee.   

Abstract

BACKGROUND: Chronic rhinosinusitis with nasal polyps (CRSwNP) or without nasal polyps (CRSsNP) is associated with expression of various cytokines. Suppressors of cytokine signaling (SOCS) regulate cytokine activity in a variety of cells, modulating inflammatory responses.
OBJECTIVE: We analyzed the expression and distribution pattern of SOCS1 and SOCS3 in CRSwNP and CRSsNP, and their cytokine-driven expression regulation in sinus mucosa. In addition, the expression levels of various cytokines were evaluated in CRSwNP and CRSsNP.
METHODS: The expression levels of SOCS1 and SOCS3 in CRSwNP and CRSsNP and in control samples were assessed by using real-time PCR, Western blot, and immunohistochemistry. Nasal epithelial cell culture was used to elucidate the effect of IL-4, IL-5, IL-6, IL-10, IL-13, IFN-γ, TNF-α, and TGF-β1 on SOCS1 and SOCS3 expression in sinus mucosa. The expression levels of these cytokines were also evaluated in normal and inflammatory sinus mucosa by using real-time PCR and Western blot.
RESULTS: The expression levels of SOCS1 and SOCS3 were increased in CRS, irrespective of the presence of nasal polyp, and they were distributed in superficial epithelium, submucosal glands, and vascular endothelium in sinus mucosa. SOCS1 was induced by IL-4, IL-13, IFN-γ, and TNF-α, while SOCS3 expression was upregulated by IL-6, IL-13, IFN-γ, and TNF-α. IL-4 and IL-13 levels were increased in CRSwNP, while IL-4, IFN-γ, TNF-α, and TGF-β1 levels were increased in CRSsNP.
CONCLUSION: SOCS1 and SOCS3 are increased in CRS, irrespective of nasal polyp presence. This may be a response to elevated levels of various cytokines increasingly expressed in inflammatory sinus mucosa.
Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23375208     DOI: 10.1016/j.jaci.2012.12.671

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  16 in total

Review 1.  Immunopathology of chronic rhinosinusitis.

Authors:  Atsushi Kato
Journal:  Allergol Int       Date:  2015-02-09       Impact factor: 5.836

Review 2.  Use of endotypes, phenotypes, and inflammatory markers to guide treatment decisions in chronic rhinosinusitis.

Authors:  Anna G Staudacher; Anju T Peters; Atsushi Kato; Whitney W Stevens
Journal:  Ann Allergy Asthma Immunol       Date:  2020-01-30       Impact factor: 6.347

Review 3.  Chronic Rhinosinusitis and the Evolving Understanding of Microbial Ecology in Chronic Inflammatory Mucosal Disease.

Authors:  Michael Hoggard; Brett Wagner Mackenzie; Ravi Jain; Michael W Taylor; Kristi Biswas; Richard G Douglas
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

4.  Bacterial extract OM-85 BV protects mice against experimental chronic rhinosinusitis.

Authors:  Yanli Tao; Tiejun Yuan; Xuechang Li; Shuqin Yang; Fanping Zhang; Li Shi
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

5.  Suppressor of cytokine signaling 3 expression is diminished in sinonasal tissues from patients with chronic rhinosinusitis with nasal polyps.

Authors:  Kathryn E Hulse; Katrina Chaung; Sudarshan Seshadri; Lydia Suh; James E Norton; Roderick G Carter; Robert C Kern; David B Conley; Rakesh K Chandra; Bruce K Tan; Anju T Peters; Leslie C Grammer; Kathleen E Harris; Troy R Torgerson; Atsushi Kato; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2013-09-29       Impact factor: 10.793

6.  TMEM16A-Mediated Mucin Secretion in IL-13-Induced Nasal Epithelial Cells From Chronic Rhinosinusitis Patients.

Authors:  Yu Zhang; Xiangdong Wang; Hong Wang; Jian Jiao; Ying Li; Erzhong Fan; Luo Zhang; Claus Bachert
Journal:  Allergy Asthma Immunol Res       Date:  2015-03-05       Impact factor: 5.764

7.  Involvement of B2 receptor in bradykinin-induced proliferation and proinflammatory effects in human nasal mucosa-derived fibroblasts isolated from chronic rhinosinusitis patients.

Authors:  Yih-Jeng Tsai; Sheng-Po Hao; Chih-Li Chen; Brian J Lin; Wen-Bin Wu
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

8.  Role of Interleukin-10 on Nasal Polypogenesis in Patients with Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Jun Xu; Ruining Han; Dae Woo Kim; Ji-Hun Mo; Yongde Jin; Ki-Sang Rha; Yong Min Kim
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

9.  Mometasone Furoate Suppresses PMA-Induced MUC-5AC and MUC-2 Production in Human Airway Epithelial Cells.

Authors:  Orapan Poachanukoon; Sittichai Koontongkaew; Paopanga Monthanapisut; Napaporn Pattanacharoenchai
Journal:  Tuberc Respir Dis (Seoul)       Date:  2016-12-30

10.  Cytokine patterns in nasal secretion of non-atopic patients distinguish between chronic rhinosinusitis with or without nasal polys.

Authors:  Katrin König; Christine Klemens; Mareike Haack; Marion San Nicoló; Sven Becker; Matthias F Kramer; Moritz Gröger
Journal:  Allergy Asthma Clin Immunol       Date:  2016-04-27       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.